| 000 | 01677 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517082025.0 | ||
| 264 | 0 | _c20171006 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1433-7339 | ||
| 024 | 7 |
_a10.1007/s00520-016-3126-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, James | |
| 245 | 0 | 0 |
_aLow serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy. _h[electronic resource] |
| 260 |
_bSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _c07 2016 |
||
| 300 |
_a3105-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBortezomib _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xcomplications |
| 650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xchemically induced |
| 650 | 0 | 4 |
_aThalidomide _xadverse effects |
| 650 | 0 | 4 |
_aVitamin D _xblood |
| 700 | 1 | _aUdd, Kyle A | |
| 700 | 1 | _aVidisheva, Aleksandra | |
| 700 | 1 | _aSwift, Regina A | |
| 700 | 1 | _aSpektor, Tanya M | |
| 700 | 1 | _aBravin, Eric | |
| 700 | 1 | _aIbrahim, Emad | |
| 700 | 1 | _aTreisman, Jonathan | |
| 700 | 1 | _aMasri, Mohammed | |
| 700 | 1 | _aBerenson, James R | |
| 773 | 0 |
_tSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _gvol. 24 _gno. 7 _gp. 3105-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00520-016-3126-1 _zAvailable from publisher's website |
| 999 |
_c25758075 _d25758075 |
||